person · Reporting owner
McGroarty Jeffrey Brian
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Annovis Bio, Inc.ANVS · Entity 7001 | Chief Financial Officer | January 03, 2022 | January 06, 2022 |
| SAFEGUARD SCIENTIFICS INCSFE · Entity 9612 | Senior VP & CFO | March 15, 2018 | March 16, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Annovis Bio, Inc.
Report date January 03, 2022 · Filed January 06, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.78 · Expires 2032-01-03 | Direct | 28,000 |
Reported balance
After 2022-01-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-01-03 · Grant · Acquired 28,000 · Balance 28,000 F1: The stock option shall vest in eight consecutive quarterly installments of 3,500 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option shall vest in eight consecutive quarterly installments of 3,500 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024.
SAFEGUARD SCIENTIFICS INC
Report date March 15, 2018 · Filed March 16, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 43,131 |
Reported balance
After 2018-03-15 transaction · row 1
1 source rowRow 1 · 2018-03-15 · Tax withholding · Disposed 270 · Balance 43,131 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2022 Filed Jan 6, 2022 00:43 UTC | Annovis Bio, Inc. ANVS · Entity 7001 | GrantStock Option (right to buy) · Derivative | 28,000 | $0.00 Strike: $19.78 | $0.00 |
DisclosureSEC source: 0001104659-22-001643 · tm221949-5_4seq1.xml · derivative · entry 1 McGroarty Jeffrey Brian · CIK 0001563273 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2032-01-03 F1 · derivative.exercise_date: The stock option shall vest in eight consecutive quarterly installments of 3,500 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 22:01 UTC | Annovis Bio, Inc. ANVS · Entity 7001 | GrantStock Option (right to buy) · Derivative | 165,199 | $0.00 Strike: $20.97 | $0.00 |
DisclosureSEC source: 0001104659-21-147676 · tm2134914d2_4seq1.xml · derivative · entry 2 McGroarty Jeffrey Brian · CIK 0001563273 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,199 Underlying: Common Stock · 165,199 shares Expires 2031-12-06 F2 · derivative.exercise_date: The stock option shall vest in two installments: (i) the first installment of 82,600 shares on March 31, 2022 and (ii) a second and final installment of 82,599 shares on March 31, 2023, provided that the reporting person continues to be employed by the issuer on the applicable vesting date. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 22:01 UTC | Annovis Bio, Inc. ANVS · Entity 7001 | GrantStock Option (right to buy) · Derivative | 30,396 | $0.00 Strike: $20.97 | $0.00 |
DisclosureSEC source: 0001104659-21-147676 · tm2134914d2_4seq1.xml · derivative · entry 1 McGroarty Jeffrey Brian · CIK 0001563273 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,396 Underlying: Common Stock · 30,396 shares Expires 2031-12-06 F1 · derivative.exercise_date: The stock option is 100% vested. Read SEC document |
| July 07, 2021 Filed Jul 9, 2021 22:28 UTC | Annovis Bio, Inc. ANVS · Entity 7001 | GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $102.85 | $0.00 |
DisclosureSEC source: 0001104659-21-090745 · tm2121908-5_4seq1.xml · derivative · entry 1 McGroarty Jeffrey Brian · CIK 0001563273 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2031-07-07 F1 · derivative.exercise_date: The stock option shall vest in eight substantially equal quarterly installments beginning October 7, 2021, provided that the reporting person continues to be employed by the issuer on the applicable vesting date. Read SEC document |
| April 09, 2020 Filed Apr 14, 2020 00:06 UTC | Annovis Bio, Inc. ANVS · Entity 7001 | GrantStock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $3.13 | $0.00 |
DisclosureSEC source: 0001104659-20-046067 · a4.xml · derivative · entry 1 McGroarty Jeffrey Brian · CIK 0001563273 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2030-04-09 F1 · derivative.exercise_date: 250,000 of the stock options are vested and exercisable as of April 9, 2020 and 50,000 of the stock options vest on April 9, 2021, provided the reporting person is employed by the registrant at such time. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 11:03 UTC | Annovis Bio, Inc. ANVS · Entity 7001 | PurchaseCommon Stock | 164 | $7.17 | $1,175.88 |
DisclosureSEC source: 0001104659-20-010938 · a4.xml · nonDerivative · entry 3 McGroarty Jeffrey Brian · CIK 0001563273 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,833 Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 11:03 UTC | Annovis Bio, Inc. ANVS · Entity 7001 | PurchaseCommon Stock | 19,336 | $7.15 | $138,252.40 |
DisclosureSEC source: 0001104659-20-010938 · a4.xml · nonDerivative · entry 2 McGroarty Jeffrey Brian · CIK 0001563273 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,669 Read SEC document |
| January 31, 2020 Filed Feb 5, 2020 11:03 UTC | Annovis Bio, Inc. ANVS · Entity 7001 | PurchaseCommon Stock | 33,333 | $6.00 | $199,998.00 |
DisclosureSEC source: 0001104659-20-010938 · a4.xml · nonDerivative · entry 1 McGroarty Jeffrey Brian · CIK 0001563273 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,333 F1 · shares: The reporting person acquired these shares in the initial public offering of Annovis Bio, Inc. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 17:33 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 270 | $12.68 | $3,422.25 |
DisclosureSEC source: 0000086115-18-000040 · wf-form4_152122159718272.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,131 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 13:57 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 557 | $12.33 | $6,865.03 |
DisclosureSEC source: 0000086115-18-000031 · wf-form4_152025824483655.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,401 Read SEC document |
| December 29, 2017 Filed Jan 2, 2018 20:21 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantCommon Stock | 12,840 | $0.00 | $0.00 |
DisclosureSEC source: 0000086115-18-000007 · wf-form4_151492446443374.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,958 Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 14:41 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 171 | $11.40 | $1,949.40 |
DisclosureSEC source: 0000086115-17-000149 · wf-form4_151360807076671.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,118 Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 15:09 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 14 | $12.23 | $171.15 |
DisclosureSEC source: 0000086115-17-000143 · wf-form4_151084498323128.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,289 Read SEC document |
| October 30, 2017 Filed Oct 31, 2017 16:10 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Exercise / conversionStock Option (right to buy) · Derivative | 875 | $0.00 Strike: $9.83 | $0.00 |
DisclosureSEC source: 0000086115-17-000136 · wf-form4_150946622985647.xml · derivative · entry 3 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 875 shares Expires 2017-10-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option vests 25% on the first anniversary of the grant date and in 36 equal monthly installments on the same date of each calendar month thereafter. Read SEC document |
| October 30, 2017 Filed Oct 31, 2017 16:10 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 695 | $13.95 | $9,695.25 |
DisclosureSEC source: 0000086115-17-000136 · wf-form4_150946622985647.xml · nonDerivative · entry 2 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,303 Read SEC document |
| October 30, 2017 Filed Oct 31, 2017 16:10 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Exercise / conversionCommon Stock | 875 | $9.83 | $8,596.88 |
DisclosureSEC source: 0000086115-17-000136 · wf-form4_150946622985647.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2017 Filed Oct 16, 2017 18:59 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 14 | $14.15 | $198.10 |
DisclosureSEC source: 0000086115-17-000125 · wf-form4_150818034512314.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,123 Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 17:23 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 184 | $12.95 | $2,382.80 |
DisclosureSEC source: 0000086115-17-000111 · wf-form4_150575537198473.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,137 Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 19:31 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 14 | $11.80 | $165.20 |
DisclosureSEC source: 0000086115-17-000103 · wf-form4_150291185622463.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,321 Read SEC document |
| July 15, 2017 Filed Jul 18, 2017 15:43 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 14 | $12.63 | $176.75 |
DisclosureSEC source: 0000086115-17-000090 · wf-form4_150039262232039.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,335 Read SEC document |
| June 15, 2017 Filed Jun 16, 2017 13:42 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 184 | $11.50 | $2,116.00 |
DisclosureSEC source: 0000086115-17-000078 · wf-form4_149762054249876.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,349 Read SEC document |
| May 15, 2017 Filed May 16, 2017 18:10 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 14 | $11.78 | $164.85 |
DisclosureSEC source: 0000086115-17-000057 · wf-form4_149495819603513.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,533 Read SEC document |
| April 15, 2017 Filed Apr 17, 2017 16:58 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 14 | $12.40 | $173.60 |
DisclosureSEC source: 0000086115-17-000045 · wf-form4_149244829615503.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,547 Read SEC document |
| March 15, 2017 Filed Mar 16, 2017 14:03 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 185 | $12.33 | $2,280.13 |
DisclosureSEC source: 0000086115-17-000033 · wf-form4_148967296858815.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,561 Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 15:24 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 427 | $12.64 | $5,397.28 |
DisclosureSEC source: 0000086115-17-000024 · wf-form4_148846826815435.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,746 Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 16:04 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 16 | $12.85 | $205.60 |
DisclosureSEC source: 0000086115-17-000020 · wf-form4_148726103533659.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,173 Read SEC document |
| January 15, 2017 Filed Jan 17, 2017 13:50 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 16 | $13.34 | $213.40 |
DisclosureSEC source: 0000086115-17-000007 · wf-form4_148466101092758.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,189 Read SEC document |
| December 30, 2016 Filed Dec 30, 2016 17:54 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantCommon Stock | 6,799 | $0.00 | $0.00 |
DisclosureSEC source: 0000086115-16-000340 · wf-form4_148312048498631.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,205 Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 14:44 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 78 | $12.35 | $963.30 |
DisclosureSEC source: 0000086115-16-000334 · wf-form4_148189945857640.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,406 Read SEC document |
| December 05, 2016 Filed Dec 6, 2016 18:02 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 5 | $11.77 | $58.84 |
DisclosureSEC source: 0000086115-16-000330 · wf-form4_148104735129177.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,484 Read SEC document |
| November 15, 2016 Filed Nov 16, 2016 16:30 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 14 | $11.93 | $166.95 |
DisclosureSEC source: 0000086115-16-000324 · wf-form4_147931381253540.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,489 Read SEC document |
| November 05, 2016 Filed Nov 7, 2016 15:21 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 5 | $10.95 | $54.75 |
DisclosureSEC source: 0000086115-16-000316 · wf-form4_147853205668638.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,503 Read SEC document |
| October 15, 2016 Filed Oct 18, 2016 12:10 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 14 | $13.02 | $182.27 |
DisclosureSEC source: 0000086115-16-000297 · wf-form4_147679259440661.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,508 Read SEC document |
| October 05, 2016 Filed Oct 6, 2016 14:54 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 5 | $13.33 | $66.63 |
DisclosureSEC source: 0000086115-16-000288 · wf-form4_147576568141127.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,522 Read SEC document |
| October 02, 2016 Filed Oct 3, 2016 18:21 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 2 | $12.94 | $25.89 |
DisclosureSEC source: 0000086115-16-000283 · wf-form4_147551889810573.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,527 Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 13:49 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 78 | $12.98 | $1,012.44 |
DisclosureSEC source: 0000086115-16-000275 · wf-form4_147403375113051.xml · nonDerivative · entry 3 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,529 Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 13:49 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Exercise / conversionStock Option (right to buy) · Derivative | 4,166 | $0.00 Strike: $7.41 | $0.00 |
DisclosureSEC source: 0000086115-16-000275 · wf-form4_147403375113051.xml · derivative · entry 4 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,166 shares Expires 2016-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option vested 25% on the first anniversary of the grant date and in 36 equal monthly installments on the same date of each calendar month thereafter. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 13:49 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 3,178 | $12.74 | $40,479.78 |
DisclosureSEC source: 0000086115-16-000275 · wf-form4_147403375113051.xml · nonDerivative · entry 2 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,607 Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 13:49 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Exercise / conversionCommon Stock | 4,166 | $7.41 | $30,870.06 |
DisclosureSEC source: 0000086115-16-000275 · wf-form4_147403375113051.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,785 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2016 Filed Sep 7, 2016 12:34 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 5 | $13.94 | $69.70 |
DisclosureSEC source: 0000086115-16-000265 · wf-form4_147325163306513.xml · nonDerivative · entry 2 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,619 Read SEC document |
| September 02, 2016 Filed Sep 7, 2016 12:34 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 2 | $13.94 | $27.88 |
DisclosureSEC source: 0000086115-16-000265 · wf-form4_147325163306513.xml · nonDerivative · entry 1 McGroarty Jeffrey B · CIK 0001563273 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,624 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.